Click here if you are having trouble viewing this email.


Sponsored by

American College of Allergy, Asthma & Immunology
Stay Connected:    Find us on Facebook Find us on Twitter LinkedIn YouTube Pinterest April 22, 2015
  Calendar   Archive   FIT

Having asthma increases risk of falling into poverty, staying there

An individual’s exposure to dust mite allergens may be People with asthma are more at risk of falling into multidimensional poverty compared with those without asthma, according to a study in Annals of Allergy, Asthma and Immunology. Researchers from the University of Sydney, Australia, found that among the subjects, 13 percent of those with asthma were in multidimensional poverty versus 8 percent of those without asthma. Having asthma also increased long-term multidimensional poverty risk by 2.22.


More adverse childhood experiences raise asthma risk

Higher numbers of adverse childhood experiences (ACEs) is associated with increased risk for asthma, according to a study in Annals of Allergy, Asthma and Immunology. Scientists from Brown University, Providence, Rhode Island, used data from the National Survey of Children’s Health to examine the relationship between single and cumulative ACEs and lifetime asthma. Hispanic children exposed to four ACEs had a 4.46 times increase in lifetime asthma and white children exposed to four ACEs had a 1.19 times increase, compared with children exposed to no ACEs.


Showcase your research at the Annual Meeting!

Submit an abstract and put your important clinical and research findings front and center at the 2015 ACAAI Annual Scientific Meeting Nov. 5-9 in San Antonio, Texas. The deadline for submissions is July 8. FITs who are starting a program on Aug. 1 may submit abstracts for consideration of a poster presentation as late as Aug. 7. Read More

   Miss something at the 2014 Annual Meeting?
   Help Postal Service employees breathe easy
   Promote your expertise to local media!
   Grants and awards available for FITs
   Get ready for ICD-10-CM with free webinars
   Studying for the ABAI exam? Give yourself an edge!
   Save on UpToDate
   Learn best research practices


Find an Allergist, Find Relief Practice Materials

Download free Asthma and Allergy Relief tools to showcase your credentials, promote your practice, and educate the public.

President's Message




text Read More

Missing New News You Can Use? Check your weekly Allergist’s Brief.

Questions? Contact your national FIT representative

Board Review Corner

Welcome to the Board Review Corner, prepared by Drs. Andrew Nickels and Sarah Spriet, senior and junior representatives of ACAAI's fellows-in-training (FITs) to the Board of Regents. The Board Review Corner is an opportunity to help hone your Board preparedness. To refer to a previous Board Review Corner, click the "FIT Archive" link on the top menu bar.


Review Questions: Cellular and Molecular Immunology, 8th Edition by Abul K. Abbas, MBBS, Andrew H. H. Lichtman, MD, PhD and Shiv Pillai, MBBS, PhD

   Chapter 4 (pages 62–74): Innate Immunity
— Prepared by Reenal Patel, MD, UMDNJ New Jersey Medical School

   Chapter 4 (pages 62-85): Innate Immunity
— Prepared by Niti Agarwal, MD, New York and Presbyterian Hospital (Columbia Campus)


Welcome to the AMA Corner managed and prepared by Alnoor A. Malick, MD, FACAAI, delegate to the AMA House of Delegates, to keep you abreast of important AMA news and developments impacting allergy-immunology.

   Should physicians Google patients?
   Taking a look at the new, evolving AMA
   New TV documentary puts spotlight on physicians and patient-centered care

News & Views Editorial

Worried about certification?
Form your own board

When ophthalmologist, senator and presidential candidate Rand Paul got crosswise with his ophthalmology board a few years ago, he simply formed his own board. That’s right. With a full membership of two and a P.O. Box mailing address, “Rand’s Board” of Ophthalmology was in business. Did it hurt him? Did it ruin his academic status? I guess we will never know until he goes back to street medicine one of these days, but he practiced 18 years. Read More




QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age or older. QVAR® is also indicated for asthma patients who require systemic corticosteroid administration, where adding QVAR® may reduce or eliminate the need for systemic corticosteroids.


Important Safety Information


QVAR® is not a bronchodilator and is not indicated for relief of acute bronchospasm


CAUTION: Adrenal insufficiency may occur when transferring patients from systemic steroids (see WARNINGS, Prescribing Information).


A reduction in growth velocity in growing children and teenagers may occur as a result of inadequate control of chronic diseases such as asthma or from use of corticosteroids for treatment


Common side effects associated with the use of QVAR® and placebo in clinical trials include, but are not limited to, headache (12% and 9% respectively) and pharyngitis (8% and 4% respectively)


Please click here for the full Prescribing Information.


Thanks to our 2015 Premier Partners – reflects contributions through mid-month


$500,000 and above


$300,000 - $499,999

Teva Respiratory


$100,000 - $299,999

    Merck     Shire   


$50,000 - $99,999


Copyright ® 2015 American College of Allergy, Asthma & Immunology. All ACAAI eNews is sent as a membership benefit of the American College of Allergy, Asthma & Immunology. E-newsletter services provided by the medical editors at Ascend Integrated Media.

Do you have news, responses or opinions to share with us? Please e-mail the association office at

To Unsubscribe from this publication, click here